Trade NEO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
NeoGenomics, Inc. (NEO) is trading at US$16.74, down 12.48% today as of Oct 6, 14:17 EDT. The company has a market capitalisation of US$2.18B. Over the past 52 weeks, NEO has traded between US$7.07 and US$20.05. On Syfe you can trade NEO with $0 commission and add it to your watchlist.
| Previous close | US$19.13 |
|---|---|
| Market cap | US$2.18B |
| P/E ratio | 55.52 |
| 52-week range | US$7.07 – US$20.05 |
| Volume | 2.03M |
| Exchange | US |
NeoGenomics, Inc.
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Year: 1996
Sector Update: Healthcare Stocks Decline Late Afternoon
Aug 27, 7:53 PM · MT Newswires
Sector Update: Healthcare
Aug 27, 7:33 PM · MT Newswires
NeoGenomics, Inc. (NEO) stock is trading at US$16.74, -12.48% from the previous close of US$19.13.
The market cap for NeoGenomics, Inc. (NEO) stock is approximately US$2.18B.
The price-to-earnings ratio for NeoGenomics, Inc. (NEO) is 55.52, based on the latest reported earnings.
The 52-week high for NeoGenomics, Inc. (NEO) stock is US$20.05.
The 52-week low for NeoGenomics, Inc. (NEO) stock is US$7.07.
NeoGenomics, Inc. (NEO) does not currently pay a dividend.
Stay on top of NEO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
